Arsenic trioxide intravenous infusion combined with transcatheter arterial chemoembolization for the

来源 :第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 | 被引量 : 0次 | 上传用户:willian1019
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Objective: To investigate the safety, clinical efficacy, and long-term outcome of TACE plus As2O3 intravenous infusion for HCC patients with pulmonary metastases.
其他文献
Objective: Tamoxifen resistance leads to lethality in a substantial fraction of estrogen positive breast cancer patients.The aim of the study is to identify the effect of PAK4 on tamoxifen resistance
目的:探讨TRAP1在乳腺病变恶性转化过程中的可能作用,分析其表达水平与乳腺癌各病理参数间的关系。方法:收集2009-04-15-2012-04-15中国医科大学附属第一医院诊治的低级别导管内癌(低级别DCIS)、高级别导管内癌(高级别DCIS)各15例和浸润性导管癌100例,以乳腺导管普通型增生(UDH)、乳腺不典型增生(ADH)各15例作为对照,应用免疫组织化学法检测上述标本中TRAP1的表达
目的:研究鹿茸多肽对乳腺癌骨转移肿瘤生长及破骨细胞的影响。方法:40只雌性SD大鼠随机分为假手术组、模型对照组、唑来膦酸组和鹿茸多肽组,每组10只。假手术组在大鼠胫骨内注射生理盐水,其他3组通过于胫骨内注射乳腺癌细胞(MRMT-1)建立乳腺癌骨转移模型,各组分别给予对应药物,模型组造模后不予处理,给药20天。
目的:乳腺癌是在我国女性中发病率居首的恶性肿瘤,且发病率正以3%的速度逐年上升,2014年已达25.89%.目前,逐渐规范的手术及辅助治疗使得乳腺癌的治愈率逐渐升高,但上肢淋巴水肿作为术后主要的并发症之一,对医生而言是一项具有挑战的问题.
Objective: Cytokine-induced killer (CIK) cells represent a realistic approach in cancer immunotherapy with confirmed survival benefits in the context of metastatic solid tumors that are unmanageable u
Objective: D2 gastrectomy is a standard procedure of curative resection for gastric cancer.This study aims to develop a simple and reliable prognostic scoring system for gastric cancer with D2 gastrec
Objective: To evaluate radiochemotherapeutic sequence for pathological stage N2 rectal cancer in the era of oxaliplatin-based adjuvant therapy.Method: Treatment outcomes and impact of different sequen
目的:本文旨在对18F-FDG-PET/CT早期预测复发转移乳腺癌缓解率的价值进行研究。方法:选择2007年~2014年复发转移的乳腺癌患者18例,所有患者均于治疗前和化疗一周期后均行PET/CT检查1次,统计分析客观缓解(OR)组与未达客观缓解(non-OR)组患者之间PET/CT1、PET/CT2、SUV、SUV变化率比较,代谢反应组与代谢无反应组患者OR、DCR的比较。
Objective: The prognosis for unresectable metastatic colorectal cancers is poor, and improved therapies are needed.Recent studies have shown the activated NLRP3 inflammasome was one of the machanism t
Objective: Patients with metastatic colorectal cancer are now recommended to profile for RAS and BRAF mutations before receiving cetuximab or panitumumab.However, lots of patients with both RAS and BR